BOUT ETF: Innovator IBD Breakout Opportunities ETF - Price, Holdings & Analysis
Innovator IBD Breakout Opportunities ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About Innovator IBD Breakout Opportunities ETF
What is the current price of BOUT?
The latest BOUT price is $47.52. The 52-week range is $35.05–$48.05. BOUT has returned 32.0% over the past 52 weeks.
What is the expense ratio for BOUT?
BOUT's annual expense ratio is 0.80%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.
Does BOUT pay dividends?
Yes, BOUT pays a 0.27% dividend yield. The last ex-dividend date was 2027-01-02. View full dividend history in the Dividends section.
What are the top holdings of BOUT?
BOUT's largest holdings are Sandisk Corp (7.2%), MapLight Therapeutics, Inc. Common Stock (6.8%), Citizens Financial Group, Inc (5.7%) (combined weight: 19.8%). The fund holds 103 total positions. View the complete portfolio breakdown in the Holdings section.
How does BOUT compare to similar ETFs?
Compare BOUT (0.80% expense ratio, $16M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.